Evaluation of the learning effect on the 6-min walk distance in adults with long COVID.

IF 4.3 3区医学 Q1 RESPIRATORY SYSTEM ERJ Open Research Pub Date : 2024-03-18 eCollection Date: 2024-03-01 DOI:10.1183/23120541.00708-2023

Tess Volckaerts, Kirsten Quadflieg, Chris Burtin, Kevin de Soomer, Ellie Oostveen, Ella Roelant, Iris Verhaegen, David Ruttens, Thérèse S Lapperre, Dirk Vissers

引用次数: 0

Abstract

There was no learning effect found on 6-min walk distance (6MWD) in patients with long COVID, performing a 6-min walk test twice. However, considerable variation in the difference between the two 6MWDs was observed: only 51% showed an increase. https://bit.ly/3H70G1r.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

评估长COVID成人六分钟步行距离的学习效果。

在撰写这封信时，全球有超过 7.7 亿人感染了实验室确诊的 2019 年冠状病毒病（COVID-19），这是一种由严重急性呼吸系统综合征冠状病毒 2（SARS-CoV-2）引起的疾病[1]。COVID-19的长期影响被称为长COVID，包括疲劳、呼吸困难、肌肉无力、焦虑、抑郁和睡眠困难[2]。美国国家健康与护理优化研究所（NICE）将长期 COVID 定义为 "在感染期间或感染后出现的与 COVID-19 一致的体征和症状，持续时间超过四周，且无法用其他诊断解释"[3]。鉴于长 COVID 是一种可持续数月的多因素疾病，NICE 指南建议在管理长 COVID 时提供多学科综合康复服务。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

ERJ Open Research Medicine-Pulmonary and Respiratory Medicine

CiteScore

6.20

自引率

4.30%

发文量

273

审稿时长

8 weeks

期刊介绍： ERJ Open Research is a fully open access original research journal, published online by the European Respiratory Society. The journal aims to publish high-quality work in all fields of respiratory science and medicine, covering basic science, clinical translational science and clinical medicine. The journal was created to help fulfil the ERS objective to disseminate scientific and educational material to its members and to the medical community, but also to provide researchers with an affordable open access specialty journal in which to publish their work.

期刊最新文献

Vascular involvement in idiopathic pulmonary fibrosis. Wearable technology for detection of COPD exacerbations: feasibility of the Health Patch. Anti-interleukin-5/anti-interleukin-5 receptor α treatment improves self-reported work productivity in patients with severe eosinophilic asthma: a prospective cohort trial. Efficacy of tezepelumab in patients with severe asthma and persistent airflow obstruction. Erratum: "Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-analysis of 65 945 individual patients". Kiki Waeijen-Smit, Mieke Crutsen, Spencer Keene, Marc Miravitlles, Ernesto Crisafulli, Antoni Torres, Christian Mueller, Philipp Schuetz, Thomas J. Ringbæk, Fabio Fabbian, Evgeni Mekov, Timothy H. Harries, Chung-tat Lun, Begum Ergan, Cristóbal Esteban, Jose M. Quintana Lopez, José Luis López-Campos, Catherina L. Chang, Robert J. Hancox, Eskandarain Shafuddin, Hollie Ellis, Christer Janson, Charlotte Suppli Ulrik, Gunnar Gudmundsson, Danny Epstein, José Dominguez, Alicia Lacoma, Christian Osadnik, Inmaculada Alia, Francesco Spannella, Zuhal Karakurt, Hossein Mehravaran, Cecile Utens, Martijn D. de Kruif, Fanny Wai San Ko, Samuel P. Trethewey, Alice M. Turner, Dragos Bumbacea, Patrick B. Murphy, Kristina Vermeersch, Shani Zilberman-Itskovich, John Steer, Carlos Echevarria, Stephen C. Bourke, Nicholas Lane, Jordi de Batlle, Roy T.M. Sprooten, Richard Russell, Paola Faverio, Jane L. Cross, Hendrik J. Prins, Martijn A. Spruit, Sami O. Simons, Sarah Houben-Wilke and Frits M.E. Franssen. ERJ Open Res 2024; 10: 00838-2023.